December 12, 2022
Japan’s market expansion re-pricing mechanism, which is triggered for drugs generating better-than-expected sales under certain conditions, is being executed too broadly with the application of the so-called “spillover” rule, academic experts discussing comprehensive pharmaceutical policies agreed on December 9. The...read more